SCHEMBL2863569

SCHEMBL2863569

COC(=O)c1ccc2[nH]nc(-c3ccccn3)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.56
PIM1 P11309 3/20 0.51
NTRK1 P04629 2/20 0.48
TGFBR1 P36897 1/20 0.47
MAP2K4 P45985 2/20 0.47
PIM2 Q9P1W9 2/20 0.47
MAPK1 P28482 2/20 0.47
KDM4E B2RXH2 3/20 0.47
STAT3 P40763 1/20 0.47
HIF1A Q16665 1/20 0.47
FLT3 P36888 1/20 0.46
KIF11 P52732 1/20 0.45
ALOX15 P16050 1/20 0.45
HTT P42858 1/20 0.45
AXL P30530 1/20 0.45
GPR84 Q9NQS5 1/20 0.44
PIM3 Q86V86 1/20 0.44
KDM6B O15054 1/20 0.44
KDM5C P41229 1/20 0.44
KDM4C Q9H3R0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2861172 0.84 LRRK2 (0.61) LRRK2PIM1NTRK1MAP2K4PIM2
SCHEMBL30864287 0.83 LRRK2 (0.60) LRRK2PIM1NTRK1MAP2K4PIM2
SCHEMBL2866668 0.81 ALOX15 (0.44) MAP2K4MAPK1KDM4ESTAT3HIF1A
SCHEMBL9986229 0.79 MAPK1 (0.58) MAP2K4MAPK1
SCHEMBL2866811 0.79 MAP2K4 (0.55) LRRK2MAP2K4MAPK1
SCHEMBL2858312 0.79 LRRK2 (0.52) LRRK2MAP2K4MAPK1KDM4ESTAT3
SCHEMBL2857478 0.79 MAP2K4 (0.52) PIM1MAP2K4MAPK1KDM4ESTAT3
SCHEMBL2861069 0.79 ALPL (0.54) MAP2K4MAPK1KDM4ESTAT3HIF1A
SCHEMBL2872662 0.79 MAPK1 (0.46) LRRK2MAPK1
SCHEMBL2857271 0.79 MAPK1 (0.46) LRRK2MAP2K4MAPK1KDM4ESTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 LRRK2 282/4885PIM1 247/4885NTRK1 1241/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 LRRK2 817/4885PIM1 194/4885NTRK1 1387/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 LRRK2 282/4885PIM1 247/4885NTRK1 1241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.